BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND KDM6A, O15550, UTX, 7403, ENSG00000147050, DKFZp686A03225, RP13-886N14_3, MGC141941, bA386N14_2 AND Treatment
15450 results:

  • 1. Development and validation of a nomogram for predicting the occurrence of renal dysfunction after treatment of immune checkpoint inhibitor: a retrospective case-control study.
    Su J; Chen P; Yang Y; Gao Z; Bi Z; Feng M
    BMJ Open; 2024 May; 14(5):e082484. PubMed ID: 38760047
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. End-stage renal disease after renal cancer surgery: risk factors and overall survival.
    Åkerlund J; Ljungberg B; Lundstam S; Peeker R; Holmberg E; Månsson M; Grenabo Bergdahl A
    Scand J Urol; 2024 May; 59():109-116. PubMed ID: 38747153
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Endoscopic intervention versus radical nephroureterectomy for the management of localized upper urinary tract urothelial carcinoma: a systematic review and meta-analysis of comparative studies.
    Giulioni C; Brocca C; Tramanzoli P; Stramucci S; Mantovan M; Perpepaj L; Cicconofri A; Gauhar V; Merseburger AS; Galosi AB; Castellani D
    World J Urol; 2024 May; 42(1):318. PubMed ID: 38743260
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Single-layer versus double-layer renorrhaphy technique during robot-assisted partial nephrectomy: impact on perioperative outcomes, complications, and functional outcomes.
    Bertolo R; Ditonno F; Veccia A; DE Marco V; Migliorini F; Porcaro AB; Rizzetto R; Cerruto MA; Autorino R; Antonelli A
    Minerva Urol Nephrol; 2024 Apr; 76(2):176-184. PubMed ID: 38742552
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Projected estimates of cancer in Canada in 2024.
    Brenner DR; Gillis J; Demers AA; Ellison LF; Billette JM; Zhang SX; Liu JL; Woods RR; Finley C; Fitzgerald N; Saint-Jacques N; Shack L; Turner D;
    CMAJ; 2024 May; 196(18):E615-E623. PubMed ID: 38740416
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Seven oral traditional Chinese medicine combined with chemotherapy for the treatment of non-small cell lung cancer: a network meta-analysis.
    Liu K; Li Q; Lu X; Fan X; Yang Y; Xie W; Kang J; Sun S; Zhao J
    Pharm Biol; 2024 Dec; 62(1):404-422. PubMed ID: 38739082
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. SPP1 expression indicates outcome of immunotherapy plus tyrosine kinase inhibition in advanced renal cell carcinoma.
    Xu X; Lin J; Wang J; Wang Y; Zhu Y; Wang J; Guo J
    Hum Vaccin Immunother; 2024 Dec; 20(1):2350101. PubMed ID: 38738709
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Receptor Targeting Using Copolymer-Modified Gold Nanoparticles for pCMV-Luc Gene Delivery to Liver Cancer Cells In Vitro.
    Zenze M; Singh M
    Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732235
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Comparison of dmft and behavior rating scores between children with systemic disease and healthy children at the first dental visit.
    Erbas Unverdi G; Ozgur B; Gungor HC; Casamassimo PS
    BMC Oral Health; 2024 May; 24(1):548. PubMed ID: 38730438
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Clinical features of patients with carcinoma soft tissue metastases as surgical indications: a retrospective cohort study.
    Morinaga S; Yamamoto N; Hayashi K; Takeuchi A; Miwa S; Igarashi K; Taniguchi Y; Asano Y; Nojima T; Tsuchiya H
    BMC Cancer; 2024 May; 24(1):577. PubMed ID: 38730358
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Automated segmentation and volume prediction in pediatric Wilms' tumor CT using nnu-net.
    Li W; Sun Y; Zhang G; Yang Q; Wang B; Ma X; Zhang H
    BMC Pediatr; 2024 May; 24(1):321. PubMed ID: 38724944
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Therapeutic Drug Monitoring of Pazopanib in Renal Cell Carcinoma and Soft Tissue Sarcoma: A Systematic Review.
    Turjap M; Pelcová M; Gregorová J; Šmak P; Martin H; Štingl J; Peš O; Juřica J
    Ther Drug Monit; 2024 Jun; 46(3):321-331. PubMed ID: 38723115
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. IL-2RG as a possible immunotherapeutic target in CRC predicting poor prognosis and regulated by miR-7-5p and miR-26b-5p.
    Gharib E; Rejali L; Piroozkhah M; Zonoobi E; Nasrabadi PN; Arabsorkhi Z; Baghdar K; Shams E; Sadeghi A; Kuppen PJK; Salehi Z; Nazemalhosseini-Mojarad E
    J Transl Med; 2024 May; 22(1):439. PubMed ID: 38720389
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Microsurgical reconstruction for head and neck in patients with end-stage renal disease undergoing dialysis.
    Hung CT; Wu MS; Wang CH; Cheng LF; Chou YF; Lee CF; Chen PR; Lee JT
    Microsurgery; 2024 May; 44(4):e31186. PubMed ID: 38716649
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. CXCR2/Snail-1-Induced Epithelial-Mesenchymal Transition in the Formation and Progression of RCC with Inferior Vena Cava Tumour Thrombus.
    Wang L; Gao J; Zheng S; Luo Z; Xu Z; Che H; Wang Z
    Arch Esp Urol; 2024 Apr; 77(3):292-302. PubMed ID: 38715171
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Current State of Liver Transplantation for Cholangiocarcinoma: A Comprehensive Literature Review.
    Mansoor J; Heaton N; Junaid Z
    Exp Clin Transplant; 2024 Mar; 22(3):167-179. PubMed ID: 38695585
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Molecular and functional characterization of reversible-sunitinib-tolerance state in human renal cell carcinoma.
    Zaccagnino A; Vynnytska-Myronovska B; Stöckle M; Junker K
    J Cell Mol Med; 2024 May; 28(9):e18329. PubMed ID: 38693863
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Epidemiology, treatment and outcomes of primary renal sarcomas in adult patients.
    Uhlig J; Uhlig A; Deshpande H; Ströbel P; Trojan L; Lotz J; Hurwitz M; Hafez O; Humphrey P; Grünwald V; Kim HS
    Sci Rep; 2024 May; 14(1):10038. PubMed ID: 38693188
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. A retrospective clinical analysis of 11 cases of PEComa from different sites.
    Yan J; Zhou D; Wang Y; Yang B; Wang Y; Zhang K; Zhang S; Zhang B; Meng Q; Lv Q
    World J Surg Oncol; 2024 Apr; 22(1):116. PubMed ID: 38689335
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Area Vulnerability and Disparities in Therapy for Patients With Metastatic Renal Cell Carcinoma.
    Rahman SN; Long JB; Westvold SJ; Leapman MS; Spees LP; Hurwitz ME; McManus HD; Gross CP; Wheeler SB; Dinan MA
    JAMA Netw Open; 2024 Apr; 7(4):e248747. PubMed ID: 38687479
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 773.